News
PR Newswire ATLANTA, June 27, 2025 ATLANTA, June 27, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety ...
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback